Bristol-Myers Squibb(施贵宝)计划今年晚些时候向英国药监局提交Xanomeline & Trospium Chloride上市授权申请

美股速递
Sep 22

Bristol-Myers Squibb(施贵宝)计划今年晚些时候向英国药品和健康产品监管署(MHRA)提交Xanomeline & Trospium Chloride的上市授权申请。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10